Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUR2-containing KATP channel complexes are hetero-octameric ion channels that serve as critical metabolic sensors, linking the cellular energetic state to membrane excitability [PubMed: 15131018]. These complexes consist of four pore-forming inward-rectifier potassium channel subunits (typically Kir6.1 or Kir6.2) and four regulatory sulfonylurea receptor 2 (SUR2) subunits, the latter encoded by the ABCC9 gene [UniProt: P59768]. SUR2 exists in two major isoforms: SUR2A, which is predominantly expressed in cardiac and skeletal muscle, and SUR2B, which is found in vascular and non-vascular smooth muscle [PubMed: 9159554]. These channels play a vital role in cardiovascular physiology, where they regulate vascular tone and provide cytoprotection during periods of metabolic stress or ischemia [PubMed: 11880371]. Pharmacologically, these complexes are the primary targets for potassium channel openers such as minoxidil and nicorandil, which induce vasodilation by promoting channel opening and subsequent membrane hyperpolarization [StatPearls: NBK539895]. Mutations in the subunits of these complexes are associated with clinical conditions including Cantu syndrome, characterized by hypertrichosis and cardiovascular abnormalities, and dilated cardiomyopathy [PubMed: 22703874].
Potassium channel opening (activator) or Potassium channel blocking (inhibitor)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfonylurea receptor 2-containing ATP-sensitive potassium channel complex (SUR2-KATP) (SUR2-KATP channel).